 |
0 Diseases |  |
0 Trials |
|
0 Trials |  |
5 News |  |
- | AAVrh.10CUCLN2 / REGENXBIO
Trial completion: AAVRh.10 Administered to Children With Late Infantile Neuronal Ceroid Lipofuscinosis (clinicaltrials.gov) - Feb 17, 2020
P1/2, N=8, Completed, Sponsor: Weill Medical College of Cornell University
Active, not recruiting --> Completed
- | AAVrh.10CUCLN2 / REGENXBIO
Enrollment closed, Trial initiation date: AAVRh.10 Administered to Children With Late Infantile Neuronal Ceroid Lipofuscinosis (clinicaltrials.gov) - Jan 9, 2018
P1/2, N=8, Active, not recruiting, Sponsor: Weill Medical College of Cornell University
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Initiation date: Dec 2010 --> Apr 2010
- AAVrh.10CUCLN2 / REGENXBIO
Trial primary completion date: AAVRh.10 Administered to Children With Late Infantile Neuronal Ceroid Lipofuscinosis (clinicaltrials.gov) - Mar 7, 2015
P1/2, N=8, Recruiting, Sponsor: Weill Medical College of Cornell University
Recruiting --> Active, not recruiting | Initiation date: Dec 2010 --> Apr 2010 Trial primary completion date: Dec 2014 --> Dec 2020
- AAVrh.10CUCLN2 / REGENXBIO
Enrollment change: AAVRh.10 Administered to Children With Late Infantile Neuronal Ceroid Lipofuscinosis (clinicaltrials.gov) - Aug 14, 2012
P1/2, N=8, Recruiting, Sponsor: Weill Medical College of Cornell University
Trial primary completion date: Dec 2014 --> Dec 2020 N=16 --> 8
- AAVrh.10CUCLN2 / REGENXBIO
New P1/2 trial: AAVRh.10 Administered to Children With Late Infantile Neuronal Ceroid Lipofuscinosis (clinicaltrials.gov) - Aug 9, 2011
P1/2, N=8, Recruiting, Sponsor: Weill Medical College of Cornell University